Both in Pharmaceuticals
Alzamend Neuro vs Vistagen Therapeutics
Over the past year ALZN returned −39.0% and VTGN returned −95.5%; their daily moves had a correlation of 0.06.
ALZN −39.0% VTGN −95.5%Growth of $1, one year, split-adjusted
| Metric | ALZN | VTGN |
|---|---|---|
| Price | $1.53 | $0.1843 |
| Market cap | $7.4M | $8.2M |
| Today | +4.79% | +9.70% |
| 1 month | +11.7% | −26.5% |
| 6 months | +39.1% | −69.8% |
| Year to date | −15.9% | −72.2% |
| 1 year | −39.8% | −95.7% |
| Revenue growth (YoY) | — | +504.9% |
| Gross margin | — | 100.0% |
| Net margin | — | −882.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 3.3× |
| Net cash | $7.6M | $31.7M |
| Dividend yield | — | — |
| Volatility (60d) | 83.1% | 107.1% |
| Short % of float | 0.7% | 5.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).